Recent studies revealed that survivin, a member of the inhibitor of apoptosis (IAP) family [27], is a good biomarker for distinguish benign and malignant thyroid nodules because it is expressed in most cancer cells, not in normal tissues [28–30]. The gene discussed is BIRC5; the disease is cancer.